From Maryland Matters
By Bruce DePuyt
January 13, 2020
EXCERPT
Members of a new prescription drug panel pledged on Monday to do a deep dive into the factors that cause consumers to experience sticker shock at the pharmacy counter.
The five-member Prescription Drug Affordability Board held its first meeting, a 90-minute organizational session, in Annapolis — under the watchful gaze of a roomful of lobbyists and other observers….
“We’re learning. This is a first-in-the-nation type of activity,” said Gerard F. Anderson, a professor of health policy and management at the Johns Hopkins University Bloomberg School of Public Health and a member of the board.
Last modified: January 14, 2020
